Medical Devices News and Research

RSS

Researchers discover easy-to-use method for bonding gels and biological tissues

Researchers have discovered an efficient and easy-to-use method for bonding together gels and biological tissues. A team headed by Ludwik Leibler, involving researchers from the Laboratoire Matière Molle et Chimie (CNRS/ESPCI ParisTech) and the Laboratoire Physico-Chimie des Polymères et Milieux Dispersés (CNRS/ UPMC/ESPCI ParisTech), has succeeded in obtaining very strong adhesion between two gels by spreading on their surface a solution containing nanoparticles.

12 Dec 2013

PPDC receives $1.5 million grant to advance pediatric medical devices

For medical devices, as with many medicines, the market for children is a small fraction of the adult market, and there are far fewer child-sized devices. But, of course, the need exists, even if proper devices may not.

12 Dec 2013

New algorithm separates signals into individual frequencies using minimal number of samples

The fast Fourier transform, one of the most important algorithms of the 20th century, revolutionized signal processing. The algorithm allowed computers to quickly perform Fourier transforms - fundamental operations that separate signals into their individual frequencies - leading to developments in audio and video engineering and digital data compression.

12 Dec 2013

Infants likely becoming exposed to potentially harmful substances via PCPs

Through lotions, shampoos and other personal care products (PCPs), infants and toddlers are likely becoming exposed to potentially harmful substances, called parabens, at an even higher level than adult women in the U.S., researchers have reported.

12 Dec 2013

Emergent BioSolutions enters into definitive agreement to acquire Cangene

Emergent BioSolutions Inc.announced that it has entered into a definitive agreement with Cangene Corporation (TSX: CNJ) under which Emergent will acquire all of the outstanding common shares of Cangene in an all-cash transaction valued at $3.24 per share on a fully diluted basis for an aggregate purchase price of $222 million.

12 Dec 2013

FDA advisory committee votes in favor of WATCHMAN Left Atrial Appendage Closure device

The U.S. Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee voted favorably by a majority, Yes: 13, No: 1, that the benefits of the WATCHMAN Left Atrial Appendage Closure device outweigh the risks.

11 Dec 2013

Surefire Medical enrolls patients in COSY clinical trial to investigate benefits of SIRT in liver metastasis

Surefire Medical, Inc. today announced that it has completed enrollment in the Coiling vs. Surefire Infusion System in Y90 (COSY) clinical trial.

11 Dec 2013

EyeTechCare's new EyeOP1 device now available in six more French health care facilities

EyeTechCare SA, which develops non-invasive therapeutic medical devices for the ophthalmology market based on the use of ultrasound, today announces that six more health care facilities in France now have the new EyeOP1 device.

11 Dec 2013

Echo Therapeutics signs strategic collaboration agreement with MTIA

Echo Therapeutics, Inc., a medical device company developing its Symphony CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it entered into a strategic collaboration agreement with Medical Technologies Innovation Asia, Ltd., Hong Kong, for a license arrangement and equity investment in Echo.

10 Dec 2013

Gecko Biomedical announces closing of Series A financing round

Gecko Biomedical, a privately owned medical device company based in Paris that is developing novel biodegradable surgical wound closure solutions, announced the closing of a €8 million ($11m) Series A financing round. The financing was co-led by Omnes Capital and CM-CIC Capital Finance, and joined by CapDecisif Management.

9 Dec 2013

Covidien signs definitive agreement to acquire outstanding shares of Given Imaging

Covidien plc and Given Imaging Ltd. today announced a definitive agreement under which Covidien will acquire all of the outstanding shares of Given Imaging for $30.00 per share in cash, for a total of approximately $860 million, net of cash and investments acquired. This transaction provides Covidien additional scale and scope to serve the multibillion dollar global gastrointestinal market and supports the Company's strategy to comprehensively address key global specialties and procedures.

8 Dec 2013

CEL-SCI gets approval to start enrollment for Multikine Phase III study for head and neck cancer

Further advancing one of the largest Phase III trials for head and neck cancer in the world, CEL-SCI Corporation announced today that it has received approval from the Agency for Medicaments and Medical Devices of the government of Bosnia and Herzegovina to begin enrollment of subjects into the Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment Multikine (Leukocyte Interleukin, Injection).

5 Dec 2013

Quality Management Certification awarded to Marken Singapore

Marken announced today that their Singapore biological kit-building facility has now been certified to International Standards Organization (ISO) 13485 standards for the storage and distribution of medical devices.

5 Dec 2013

St. Jude Medical evaluates effectiveness of PNfS and SCS for chronic low back and leg pain

St. Jude Medical, Inc., a global medical device company, has launched a clinical study to evaluate the combination of peripheral nerve field stimulation, and spinal cord stimulation, to determine whether the two therapies together offer more effective management of chronic low back and leg pain than SCS alone. The first patient in the SENSE Subcutaneous and Epidural Neuromodulation System Evaluation study was enrolled by Dr. Thomas Yearwood, an interventional pain physician at Comprehensive Pain & Rehabilitation in Pascagoula, Miss.

5 Dec 2013

Viewpoints: Why can't health website be like Amazon?; debunking GOP's resistance to Medicaid

For an "Amazon-like" experience, it isn't enough to have a website that functions on the front end, the back end and in between. ... You also need an Amazon-like culture, which is the product of other Amazon-like realities.

5 Dec 2013

Researchers present new method of wirelessly recharging medical device batteries with ultrasound

Human beings don't come with power sockets, but a growing numbers of us have medical implants that run off electricity. To keep our bionic body parts from powering down, a group of Arizona researchers is developing a safe, noninvasive, and efficient means of wireless power transmission through body tissue.

5 Dec 2013

TYRX receives FDA clearance to market AIGISRx N Antibacterial Envelope

TYRX, Inc. announced today that it has received U.S. Food and Drug Administration clearance for expanded indications in marketing the AIGISRx N Antibacterial Envelope for use with spinal cord neuromodulators.

5 Dec 2013

Update on reimbursement coverage for Percutaneous Tibial Nerve Stimulation procedures

Uroplasty, Inc. a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today provided an update on reimbursement coverage for Percutaneous Tibial Nerve Stimulation (PTNS) procedures delivered via the Company's Urgent® PC Neuromodulation System for treatment of overactive bladder (OAB) and associated symptoms of urinary urgency, urinary frequency and urge incontinence.

4 Dec 2013

mHealth, Cloud in Healthcare and Regulatory Environments predicted to be the key subjects in 2014

Frost & Sullivan released today its three big predictions for the global healthcare market. Based on a '2013 Search for Growth' survey which involved 1835 executives in more than 40 countries worldwide, Frost & Sullivan's insight highlights new areas of growth. mHealth, Cloud in Healthcare and Regulatory Environments will be the key subjects in 2014 and beyond.

4 Dec 2013

Dye reduction in diagnostic heart procedures: an interview with Mike McCormick, CEO Osprey Medical

Iodine based contrast media (dye) is radiopaque and is commonly used for diagnostic and interventional heart procedures. It allows physicians to see real time images of the heart vessels and treat any blockages.

3 Dec 2013

Medical Devices News and Research

Researchers discover easy-to-use method for bonding gels and biological tissues

PPDC receives $1.5 million grant to advance pediatric medical devices

New algorithm separates signals into individual frequencies using minimal number of samples

Infants likely becoming exposed to potentially harmful substances via PCPs

Emergent BioSolutions enters into definitive agreement to acquire Cangene

FDA advisory committee votes in favor of WATCHMAN Left Atrial Appendage Closure device

Surefire Medical enrolls patients in COSY clinical trial to investigate benefits of SIRT in liver metastasis

EyeTechCare's new EyeOP1 device now available in six more French health care facilities

Echo Therapeutics signs strategic collaboration agreement with MTIA

Gecko Biomedical announces closing of Series A financing round

Covidien signs definitive agreement to acquire outstanding shares of Given Imaging

CEL-SCI gets approval to start enrollment for Multikine Phase III study for head and neck cancer

Quality Management Certification awarded to Marken Singapore

St. Jude Medical evaluates effectiveness of PNfS and SCS for chronic low back and leg pain

Viewpoints: Why can't health website be like Amazon?; debunking GOP's resistance to Medicaid

Researchers present new method of wirelessly recharging medical device batteries with ultrasound

TYRX receives FDA clearance to market AIGISRx N Antibacterial Envelope

Update on reimbursement coverage for Percutaneous Tibial Nerve Stimulation procedures

mHealth, Cloud in Healthcare and Regulatory Environments predicted to be the key subjects in 2014

Dye reduction in diagnostic heart procedures: an interview with Mike McCormick, CEO Osprey Medical

Industry Focus - Medical Device eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News